| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.003 | 0.733 | Alcohol oxidase inhibitor | 0.572 0.003 CID_65512 | ||
| 0.706 | 0.002 | 0.706 | Porphobilinogen synthase inhibitor | 0.567 0.003 CID_65512 | ||
| 0.651 | 0.013 | 0.651 | Aldehyde oxidase inhibitor | 0.358 0.054 CID_65512 | ||
| 0.625 | 0.002 | 0.625 | Carbonic anhydrase XV inhibitor | 0.427 0.004 CID_65512 | ||
| 0.613 | 0.004 | 0.613 | Peroxidase inhibitor | 0.445 0.015 CID_65512 | ||
| 0.605 | 0.003 | 0.605 | GABA C receptor agonist | 0.283 0.01 CID_65512 | ||
| 0.568 | 0.016 | 0.638 | 5 Hydroxytryptamine release inhibitor | 0.638 0.007 CID_65512 | CID_65512 | |
| 0.556 | 0.009 | 0.556 | Superoxide dismutase inhibitor | 0.385 0.029 CID_65512 | ||
| 0.554 | 0.014 | 0.554 | GABA C receptor rho-3 antagonist | 0.366 0.078 CID_65512 | ||
| 0.562 | 0.024 | 0.562 | Cholesterol antagonist | 0.466 0.038 CID_65512 | ||
| 0.553 | 0.016 | 0.625 | Histamine release inhibitor | 0.625 0.008 CID_65512 | CID_65512 | |
| 0.534 | 0.005 | 0.534 | Phospholipase C inhibitor | 0.328 0.016 CID_65512 | ||
| 0.492 | 0.003 | 0.492 | GABA aminotransferase inhibitor | 0.157 0.007 CID_65512 | ||
| 0.507 | 0.019 | 0.507 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.493 0.021 CID_65512 | ||
| 0.52 | 0.041 | 0.52 | Transcription factor NF kappa B inhibitor | 0.432 0.057 CID_65512 | ||
| 0.486 | 0.009 | 0.486 | Anesthetic general | 0.36 0.022 CID_65512 | ||
| 0.512 | 0.037 | 0.512 | Antibacterial | 0.446 0.058 CID_65512 | ||
| 0.477 | 0.003 | 0.477 | Histidine decarboxylase inhibitor | 0.317 0.005 CID_65512 | ||
| 0.494 | 0.03 | 0.494 | Calcium channel L-type activator | 0.447 0.052 CID_65512 | ||
| 0.467 | 0.006 | 0.738 | Alpha-N-acetylglucosaminidase inhibitor | 0.738 0.003 CID_65512 | CID_65512 | |
| 0.444 | 0.005 | 0.444 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.395 0.008 CID_65512 | ||
| 0.438 | 0.003 | 0.438 | CD45 antagonist | 0.298 0.004 CID_65512 | ||
| 0.448 | 0.016 | 0.45 | Interleukin 2 agonist | 0.45 0.015 CID_65512 | CID_65512 | |
| 0.436 | 0.006 | 0.436 | Lipocortins synthesis antagonist | 0.271 0.027 CID_65512 | ||
| 0.433 | 0.014 | 0.479 | Interleukin agonist | 0.479 0.01 CID_65512 | CID_65512 | |
| 0.424 | 0.01 | 0.424 | 5 Hydroxytryptamine uptake stimulant | 0.342 0.028 CID_65512 | ||
| 0.421 | 0.016 | 0.421 | RNA-directed DNA polymerase inhibitor | 0.266 0.041 CID_65512 | ||
| 0.493 | 0.09 | 0.493 | Antiinflammatory | 0.384 0.149 CID_65512 | ||
| 0.415 | 0.012 | 0.415 | Dual specificity phosphatase 3 inhibitor | 0.343 0.022 CID_65512 | ||
| 0.421 | 0.019 | 0.421 | DNA synthesis inhibitor | 0.301 0.043 CID_65512 | ||
| 0.409 | 0.011 | 0.409 | Monophenol monooxygenase inhibitor | 0.326 0.015 CID_65512 | ||
| 0.456 | 0.058 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.489 0.039 CID_65512 | CID_65512 | |
| 0.406 | 0.01 | 0.406 | Mcl-1 antagonist | 0.329 0.018 CID_65512 | ||
| 0.403 | 0.008 | 0.403 | Protein-tyrosine phosphatase inhibitor | 0.331 0.014 CID_65512 | ||
| 0.397 | 0.006 | 0.416 | UDP-glucose 4-epimerase inhibitor | 0.416 0.005 CID_65512 | CID_65512 | |
| 0.39 | 0.003 | 0.39 | HIV-1 integrase (Overall Integration) inhibitor | 0.232 0.006 CID_65512 | ||
| 0.387 | 0.004 | 0.387 | Succinate dehydrogenase inhibitor | 0.337 0.006 CID_65512 | ||
| 0.396 | 0.015 | 0.396 | Dual specificity phosphatase inhibitor | 0.336 0.023 CID_65512 | ||
| 0.385 | 0.004 | 0.385 | Carbonic anhydrase III inhibitor | 0.318 0.005 CID_65512 | ||
| 0.383 | 0.005 | 0.383 | Cystathionine beta-synthase inhibitor | 0.208 0.023 CID_65512 | ||
| 0.435 | 0.06 | 0.435 | 15-Lipoxygenase inhibitor | 0.346 0.102 CID_65512 | ||
| 0.399 | 0.025 | 0.399 | Calcium channel activator | 0.301 0.091 CID_65512 | ||
| 0.377 | 0.004 | 0.377 | Catenin beta inhibitor | 0.307 0.005 CID_65512 | ||
| 0.387 | 0.021 | 0.387 | Sodium/bile acid cotransporter inhibitor | 0.384 0.022 CID_65512 | ||
| 0.359 | 0.005 | 0.372 | Interleukin 4 antagonist | 0.372 0.005 CID_65512 | CID_65512 | |
| 0.362 | 0.018 | 0.362 | Non-steroidal antiinflammatory agent | 0.276 0.034 CID_65512 | ||
| 0.377 | 0.033 | 0.377 | Free radical scavenger | 0.298 0.052 CID_65512 | ||
| 0.348 | 0.004 | 0.348 | Potassium channel (Ca-activated) activator | 0.195 0.015 CID_65512 | ||
| 0.367 | 0.035 | 0.367 | Antiamyloidogenic | 0.267 0.064 CID_65512 | ||
| 0.339 | 0.008 | 0.339 | NADPH oxidase inhibitor | 0.29 0.014 CID_65512 | ||
| 0.331 | 0.005 | 0.371 | Ferrochelatase inhibitor | 0.371 0.004 CID_65512 | CID_65512 | |
| 0.37 | 0.043 | 0.37 | Aryl hydrocarbon receptor agonist | 0.345 0.049 CID_65512 | ||
| 0.339 | 0.016 | 0.339 | DNA methyltransferase I inhibitor | 0.331 0.017 CID_65512 | ||
| 0.329 | 0.008 | 0.351 | Hexokinase inhibitor | 0.351 0.006 CID_65512 | CID_65512 | |
| 0.324 | 0.006 | 0.324 | NADH dehydrogenase inhibitor | 0.158 0.016 CID_65512 | ||
| 0.365 | 0.051 | 0.365 | 12-Lipoxygenase inhibitor | 0.356 0.055 CID_65512 | ||
| 0.327 | 0.012 | 0.327 | Amyloid beta precursor protein antagonist | 0.272 0.025 CID_65512 | ||
| 0.318 | 0.004 | 0.318 | Keratolytic | 0.282 0.004 CID_65512 | ||
| 0.331 | 0.021 | 0.331 | Tyrosine 3 hydroxylase inhibitor | 0.278 0.045 CID_65512 | ||
| 0.352 | 0.046 | 0.352 | Antioxidant | 0.274 0.072 CID_65512 | ||
| 0.309 | 0.005 | 0.309 | Alcohol dehydrogenase inhibitor | 0.21 0.011 CID_65512 | ||
| 0.31 | 0.006 | 0.31 | Carbonic anhydrase VI inhibitor | 0.155 0.02 CID_65512 | ||
| 0.321 | 0.022 | 0.321 | DNA methylase inhibitor | 0.298 0.028 CID_65512 | ||
| 0.303 | 0.005 | 0.303 | Triose-phosphate isomerase inhibitor | 0.223 0.009 CID_65512 | ||
| 0.297 | 0.004 | 0.297 | Glutamate decarboxylase inhibitor | 0.175 0.009 CID_65512 | ||
| 0.296 | 0.004 | 0.296 | Electrolyte absorption antagonist | 0.26 0.005 CID_65512 | ||
| 0.295 | 0.006 | 0.295 | Carbonic anhydrase XIII inhibitor | 0.185 0.016 CID_65512 | ||
| 0.292 | 0.004 | 0.292 | NMDA 2A receptor antagonist | 0.134 0.008 CID_65512 | ||
| 0.329 | 0.042 | 0.472 | Transcription factor STAT inhibitor | 0.472 0.01 CID_65512 | CID_65512 | |
| 0.303 | 0.018 | 0.303 | Amylase inhibitor | 0.159 0.06 CID_65512 | ||
| 0.328 | 0.043 | 0.348 | Insulysin inhibitor | 0.348 0.035 CID_65512 | CID_65512 | |
| 0.288 | 0.006 | 0.288 | Phosphofructokinase-1 inhibitor | 0.157 0.017 CID_65512 | ||
| 0.335 | 0.056 | 0.335 | Lipoxygenase inhibitor | 0.274 0.084 CID_65512 | ||
| 0.296 | 0.019 | 0.296 | Neurotrophic factor enhancer | 0.218 0.06 CID_65512 | ||
| 0.28 | 0.005 | 0.28 | NMDA 2 receptor antagonist | 0.153 0.016 CID_65512 | ||
| 0.337 | 0.062 | 0.337 | Apoptosis antagonist | 0.303 0.084 CID_65512 | ||
| 0.318 | 0.045 | 0.457 | Transcription factor STAT3 inhibitor | 0.457 0.01 CID_65512 | CID_65512 | |
| 0.278 | 0.009 | 0.278 | Xanthine oxidase inhibitor | 0.232 0.014 CID_65512 | ||
| 0.29 | 0.021 | 0.29 | Interferon gamma antagonist | 0.248 0.029 CID_65512 | ||
| 0.276 | 0.008 | 0.276 | Adenylate kinase inhibitor | 0.15 0.026 CID_65512 | ||
| 0.272 | 0.004 | 0.272 | Phenylalanine 4-hydroxylase inhibitor | 0.146 0.012 CID_65512 | ||
| 0.335 | 0.069 | 0.351 | Immunostimulant | 0.351 0.064 CID_65512 | CID_65512 | |
| 0.27 | 0.005 | 0.27 | HIV-1 integrase (3'-Processing) inhibitor | 0.208 0.009 CID_65512 | ||
| 0.285 | 0.021 | 0.285 | I kappa B kinase epsilon inhibitor | 0.207 0.065 CID_65512 | ||
| 0.269 | 0.005 | 0.269 | Creatine kinase inhibitor | 0.195 0.011 CID_65512 | ||
| 0.274 | 0.013 | 0.274 | Protein-tyrosine phosphatase 1B inhibitor | 0.236 0.019 CID_65512 | ||
| 0.262 | 0.002 | 0.262 | Purinergic P2X1 antagonist | 0.191 0.004 CID_65512 | ||
| 0.307 | 0.047 | 0.307 | Angiogenesis stimulant | 0.234 0.077 CID_65512 | ||
| 0.262 | 0.002 | 0.262 | D-Ala-D-Ala ligase inhibitor | 0.17 0.004 CID_65512 | ||
| 0.295 | 0.036 | 0.328 | Gastrin inhibitor | 0.328 0.018 CID_65512 | CID_65512 | |
| 0.269 | 0.011 | 0.276 | Expectorant | 0.276 0.01 CID_65512 | CID_65512 | |
| 0.262 | 0.006 | 0.262 | Uric acid excretion stimulant | 0.22 0.01 CID_65512 | ||
| 0.269 | 0.014 | 0.269 | Chelator | 0.218 0.021 CID_65512 | ||
| 0.257 | 0.004 | 0.257 | DOPA decarboxylase inhibitor | 0.171 0.013 CID_65512 | ||
| 0.262 | 0.008 | 0.262 | NMDA receptor antagonist | 0.163 0.021 CID_65512 | ||
| 0.257 | 0.006 | 0.257 | GABA C receptor antagonist | 0.124 0.048 CID_65512 | ||
| 0.295 | 0.044 | 0.295 | Cyclic AMP phosphodiesterase inhibitor | 0.23 0.074 CID_65512 | ||
| 0.267 | 0.017 | 0.267 | Adenylate cyclase inhibitor | 0.165 0.036 CID_65512 | ||
| 0.295 | 0.046 | 0.295 | Amyloid beta aggregation inhibitor | 0.198 0.079 CID_65512 | ||
| 0.258 | 0.01 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.169 0.05 CID_65512 | ||
| 0.336 | 0.088 | 0.336 | Prostaglandin dehydrogenase inhibitor | 0.234 0.135 CID_65512 | ||
| 0.372 | 0.128 | 0.372 | Apoptosis agonist | 0.307 0.167 CID_65512 | ||
| 0.291 | 0.05 | 0.291 | Pyruvate kinase inhibitor | 0.219 0.072 CID_65512 | ||
| 0.266 | 0.026 | 0.266 | Insulin sensitizer | 0.255 0.032 CID_65512 | ||
| 0.245 | 0.005 | 0.245 | Potassium channel large-conductance Ca-activated activator | 0.123 0.016 CID_65512 | ||
| 0.243 | 0.005 | 0.243 | GABA C receptor rho-1 antagonist | 0.124 0.036 CID_65512 | ||
| 0.258 | 0.021 | 0.258 | Phospholipase A2 inhibitor | 0.244 0.025 CID_65512 | ||
| 0.246 | 0.01 | 0.303 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.303 0.006 CID_65512 | CID_65512 | |
| 0.243 | 0.007 | 0.243 | HIV-1 integrase (Strand Transfer) inhibitor | 0.165 0.012 CID_65512 | ||
| 0.238 | 0.005 | 0.238 | NMDA 2C receptor antagonist | 0.118 0.011 CID_65512 | ||
| 0.24 | 0.007 | 0.27 | Mucolytic | 0.27 0.005 CID_65512 | CID_65512 | |
| 0.251 | 0.02 | 0.251 | Anesthetic local | 0.183 0.037 CID_65512 | ||
| 0.239 | 0.01 | 0.36 | Cyclooxygenase 3 inhibitor | 0.36 0.004 CID_65512 | CID_65512 | |
| 0.233 | 0.003 | 0.251 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.251 0.003 CID_65512 | CID_65512 | |
| 0.229 | 0.005 | 0.229 | Biliverdin reductase inhibitor | 0.142 0.01 CID_65512 | ||
| 0.229 | 0.007 | 0.229 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.145 0.02 CID_65512 | ||
| 0.243 | 0.022 | 0.279 | M17 leucyl aminopeptidase inhibitor | 0.279 0.015 CID_65512 | CID_65512 | |
| 0.356 | 0.135 | 0.489 | DNA directed DNA polymerase inhibitor | 0.489 0.086 CID_65512 | CID_65512 | |
| 0.231 | 0.014 | 0.252 | Protein kinase (CK2) inhibitor | 0.252 0.011 CID_65512 | CID_65512 | |
| 0.245 | 0.028 | 0.245 | Heat shock protein 90 alpha antagonist | 0.218 0.04 CID_65512 | ||
| 0.224 | 0.008 | 0.224 | Glutamate dehydrogenase inhibitor | 0.148 0.016 CID_65512 | ||
| 0.263 | 0.048 | 0.263 | MAP kinase kinase 2 inhibitor | 0.164 0.109 CID_65512 | ||
| 0.218 | 0.004 | 0.218 | Carbonic anhydrase XIV inhibitor | 0.143 0.005 CID_65512 | ||
| 0.242 | 0.029 | 0.242 | Protein kinase stimulant | 0.209 0.038 CID_65512 | ||
| 0.228 | 0.017 | 0.228 | GABA C receptor rho-2 antagonist | 0.146 0.079 CID_65512 | ||
| 0.284 | 0.074 | 0.284 | Hypoxia-inducible factor 1 alpha inhibitor | 0.194 0.159 CID_65512 | ||
| 0.214 | 0.004 | 0.214 | Kainate receptor antagonist | 0.064 0.014 CID_65512 | ||
| 0.339 | 0.13 | 0.339 | Cyclophilin D inhibitor | 0.267 0.194 CID_65512 | ||
| 0.297 | 0.09 | 0.313 | Antithrombotic | 0.313 0.08 CID_65512 | CID_65512 | |
| 0.288 | 0.084 | 0.288 | Streptokinase A inhibitor | 0.282 0.087 CID_65512 | ||
| 0.208 | 0.004 | 0.208 | Xanthine dehydrogenase inhibitor | 0.146 0.008 CID_65512 | ||
| 0.223 | 0.02 | 0.289 | Protein kinase (CK2) alpha inhibitor | 0.289 0.012 CID_65512 | CID_65512 | |
| 0.231 | 0.027 | 0.231 | Topoisomerase II inhibitor | 0.149 0.05 CID_65512 | ||
| 0.339 | 0.141 | 0.448 | Alpha-glucosidase inhibitor | 0.448 0.096 CID_65512 | CID_65512 | |
| 0.202 | 0.006 | 0.202 | Heat shock protein 70 antagonist | 0.199 0.006 CID_65512 | ||
| 0.259 | 0.064 | 0.259 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.16 0.122 CID_65512 | ||
| 0.198 | 0.002 | 0.198 | Dihydropteroate synthase inhibitor | 0.146 0.004 CID_65512 | ||
| 0.218 | 0.024 | 0.218 | Cell wall synthesis inhibitor | 0.218 0.024 CID_65512 | ||
| 0.283 | 0.088 | 0.283 | Caspase 3 stimulant | 0.248 0.114 CID_65512 | ||
| 0.215 | 0.021 | 0.215 | Arachidonic acid antagonist | 0.18 0.054 CID_65512 | ||
| 0.197 | 0.005 | 0.197 | Myeloperoxidase inhibitor | 0.092 0.046 CID_65512 | ||
| 0.194 | 0.004 | 0.194 | Topoisomerase II beta inhibitor | 0.161 0.005 CID_65512 | ||
| 0.236 | 0.047 | 0.236 | MAP kinase kinase 3 inhibitor | |||
| 0.207 | 0.018 | 0.207 | CF transmembrane conductance regulator agonist | 0.187 0.03 CID_65512 | ||
| 0.217 | 0.028 | 0.217 | Cyclooxygenase 1 inhibitor | 0.123 0.077 CID_65512 | ||
| 0.234 | 0.045 | 0.234 | Nitric-oxide synthase stimulant | 0.199 0.09 CID_65512 | ||
| 0.215 | 0.028 | 0.215 | Alkaline phosphatase inhibitor | 0.181 0.042 CID_65512 | ||
| 0.192 | 0.005 | 0.219 | NMDA receptor agonist | 0.219 0.004 CID_65512 | CID_65512 | |
| 0.205 | 0.02 | 0.205 | Farnesoid X receptor antagonist | 0.18 0.029 CID_65512 | ||
| 0.188 | 0.005 | 0.255 | Neuraminidase (influenza) inhibitor | 0.255 0.004 CID_65512 | CID_65512 | |
| 0.22 | 0.037 | 0.22 | Diuretic | 0.189 0.049 CID_65512 | ||
| 0.187 | 0.005 | 0.187 | Glutamate release inhibitor | 0.086 0.072 CID_65512 | ||
| 0.2 | 0.018 | 0.2 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.171 0.041 CID_65512 | ||
| 0.215 | 0.033 | 0.215 | Interleukin 6 antagonist | |||
| 0.193 | 0.012 | 0.211 | Papain-like protease (SARS coronavirus) inhibitor | 0.211 0.008 CID_65512 | CID_65512 | |
| 0.251 | 0.071 | 0.251 | Dyrk kinase inhibitor | 0.149 0.137 CID_65512 | ||
| 0.18 | 0.002 | 0.18 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 CID_65512 | ||
| 0.181 | 0.003 | 0.181 | Adenine nucleotide translocase inhibitor | 0.154 0.003 CID_65512 | ||
| 0.179 | 0.004 | 0.179 | Maillard reaction inhibitor | 0.133 0.008 CID_65512 | ||
| 0.191 | 0.016 | 0.229 | Sphingosine 1-phosphate receptor 5 antagonist | 0.229 0.005 CID_65512 | CID_65512 | |
| 0.211 | 0.037 | 0.211 | Lipid peroxidase inhibitor | 0.188 0.047 CID_65512 | ||
| 0.227 | 0.054 | 0.227 | Sigma receptor agonist | |||
| 0.178 | 0.005 | 0.258 | Neuraminidase inhibitor | 0.258 0.003 CID_65512 | CID_65512 | |
| 0.325 | 0.152 | 0.491 | DNA polymerase beta inhibitor | 0.491 0.089 CID_65512 | CID_65512 | |
| 0.181 | 0.009 | 0.181 | Argininosuccinate synthase inhibitor | 0.081 0.025 CID_65512 | ||
| 0.179 | 0.007 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_65512 | ||
| 0.181 | 0.009 | 0.181 | Adrenaline agonist | 0.166 0.011 CID_65512 | ||
| 0.19 | 0.019 | 0.19 | Adenylate cyclase stimulant | 0.133 0.095 CID_65512 | ||
| 0.247 | 0.079 | 0.247 | Hypoglycemic | 0.178 0.137 CID_65512 | ||
| 0.196 | 0.029 | 0.196 | DNA polymerase I inhibitor | 0.151 0.048 CID_65512 | ||
| 0.202 | 0.037 | 0.202 | Heat shock protein 90 antagonist | 0.153 0.072 CID_65512 | ||
| 0.192 | 0.03 | 0.192 | Aldehyde dehydrogenase inhibitor | 0.104 0.092 CID_65512 | ||
| 0.195 | 0.035 | 0.195 | M18 aspartyl aminopeptidase inhibitor | 0.147 0.054 CID_65512 | ||
| 0.164 | 0.005 | 0.164 | Glycine receptor agonist | 0.087 0.031 CID_65512 | ||
| 0.211 | 0.054 | 0.211 | Histone acetyltransferase inhibitor | |||
| 0.172 | 0.017 | 0.172 | AMP-activated protein kinase stimulant | 0.16 0.022 CID_65512 | ||
| 0.166 | 0.012 | 0.166 | Macrophage migration inhibitory factor inhibitor | 0.094 0.038 CID_65512 | ||
| 0.18 | 0.026 | 0.18 | Aminopeptidase B inhibitor | 0.15 0.038 CID_65512 | ||
| 0.156 | 0.005 | 0.156 | Plasminogen activator inhibitor antagonist | 0.121 0.007 CID_65512 | ||
| 0.15 | 0.004 | 0.177 | NMDA receptor glycine site agonist | 0.177 0.004 CID_65512 | CID_65512 | |
| 0.151 | 0.006 | 0.151 | NMDA receptor subunit 3B antagonist | 0.08 0.014 CID_65512 | ||
| 0.167 | 0.023 | 0.167 | Protein kinase C gamma inhibitor | 0.113 0.059 CID_65512 | ||
| 0.157 | 0.014 | 0.157 | Anabolic | 0.147 0.02 CID_65512 | ||
| 0.148 | 0.008 | 0.148 | Bile acid receptor antagonist | 0.126 0.015 CID_65512 | ||
| 0.144 | 0.004 | 0.144 | Aconitate hydratase inhibitor | 0.067 0.02 CID_65512 | ||
| 0.153 | 0.014 | 0.153 | Carbonic anhydrase V inhibitor | 0.144 0.016 CID_65512 | ||
| 0.214 | 0.075 | 0.214 | ErbB-1 antagonist | |||
| 0.181 | 0.042 | 0.181 | Hemostatic | 0.174 0.046 CID_65512 | ||
| 0.162 | 0.025 | 0.162 | Photosensitizer | 0.132 0.045 CID_65512 | ||
| 0.14 | 0.005 | 0.14 | GABA B receptor agonist | 0.121 0.007 CID_65512 | ||
| 0.145 | 0.01 | 0.145 | Acyl-CoA dehydrogenase inhibitor | 0.09 0.019 CID_65512 | ||
| 0.169 | 0.035 | 0.169 | Cathepsin H inhibitor | 0.124 0.07 CID_65512 | ||
| 0.138 | 0.005 | 0.138 | NMDA receptor subunit 3A antagonist | 0.059 0.017 CID_65512 | ||
| 0.181 | 0.049 | 0.183 | Neurotensin receptor agonist | 0.183 0.047 CID_65512 | CID_65512 | |
| 0.141 | 0.01 | 0.141 | Carbonic anhydrase VB inhibitor | 0.08 0.023 CID_65512 | ||
| 0.134 | 0.002 | 0.134 | Glutamate (mGluR8) agonist | 0.079 0.004 CID_65512 | ||
| 0.153 | 0.022 | 0.163 | Urease inhibitor | 0.163 0.018 CID_65512 | CID_65512 | |
| 0.159 | 0.028 | 0.159 | Interleukin 8 antagonist | 0.107 0.081 CID_65512 | ||
| 0.156 | 0.026 | 0.187 | Mediator release inhibitor | 0.187 0.017 CID_65512 | CID_65512 | |
| 0.131 | 0.003 | 0.162 | Dihydroorotate oxidase inhibitor | 0.162 0.002 CID_65512 | CID_65512 | |
| 0.194 | 0.066 | 0.194 | LIM domain kinase 1 inhibitor | 0.145 0.103 CID_65512 | ||
| 0.253 | 0.125 | 0.336 | Vasodilator, peripheral | 0.336 0.08 CID_65512 | CID_65512 | |
| 0.134 | 0.009 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 CID_65512 | ||
| 0.138 | 0.013 | 0.138 | Carbonic anhydrase VA inhibitor | 0.132 0.015 CID_65512 | ||
| 0.141 | 0.018 | 0.141 | Toll-Like receptor 3 antagonist | |||
| 0.139 | 0.015 | 0.139 | Ornithine decarboxylase inhibitor | 0.108 0.036 CID_65512 | ||
| 0.152 | 0.03 | 0.152 | DNA repair enzyme inhibitor | 0.119 0.073 CID_65512 | ||
| 0.156 | 0.034 | 0.194 | Falcipain 3 inhibitor | 0.194 0.019 CID_65512 | CID_65512 | |
| 0.129 | 0.009 | 0.129 | Phosphorylase inhibitor | 0.098 0.013 CID_65512 | ||
| 0.153 | 0.037 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.19 0.01 CID_65512 | CID_65512 | |
| 0.134 | 0.019 | 0.134 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.122 0.024 CID_65512 | ||
| 0.178 | 0.063 | 0.178 | Thrombolytic | 0.146 0.085 CID_65512 | ||
| 0.117 | 0.006 | 0.117 | Glutamate (mGluR6) antagonist | 0.079 0.025 CID_65512 | ||
| 0.139 | 0.029 | 0.218 | Catalase inhibitor | 0.218 0.012 CID_65512 | CID_65512 | |
| 0.195 | 0.087 | 0.295 | Interleukin antagonist | 0.295 0.049 CID_65512 | CID_65512 | |
| 0.152 | 0.045 | 0.152 | Alkylator | 0.112 0.075 CID_65512 | ||
| 0.132 | 0.025 | 0.132 | MAP kinase kinase 1 inhibitor | 0.087 0.075 CID_65512 | ||
| 0.142 | 0.036 | 0.142 | CC chemokine 6 receptor antagonist | 0.136 0.051 CID_65512 | ||
| 0.11 | 0.004 | 0.15 | Nicotinic acid receptor agonist | 0.15 0.004 CID_65512 | CID_65512 | |
| 0.14 | 0.036 | 0.197 | Caspase 3 inhibitor | 0.197 0.01 CID_65512 | CID_65512 | |
| 0.141 | 0.038 | 0.153 | TRPA1 agonist | 0.153 0.029 CID_65512 | CID_65512 | |
| 0.119 | 0.016 | 0.119 | HIV-1 integrase inhibitor | 0.098 0.026 CID_65512 | ||
| 0.166 | 0.063 | 0.166 | Melanin inhibitor | 0.157 0.073 CID_65512 | ||
| 0.109 | 0.007 | 0.109 | MAP kinase kinase 7 inhibitor | 0.094 0.019 CID_65512 | ||
| 0.157 | 0.055 | 0.157 | Neuropeptide Y1 antagonist | 0.15 0.065 CID_65512 | ||
| 0.127 | 0.025 | 0.127 | Histamine N-methyltransferase inhibitor | |||
| 0.213 | 0.111 | 0.213 | 5 Hydroxytryptamine release stimulant | |||
| 0.128 | 0.028 | 0.128 | Protein kinase C zeta inhibitor | |||
| 0.104 | 0.004 | 0.104 | Ryanodine receptor antagonist | 0.059 0.039 CID_65512 | ||
| 0.199 | 0.1 | 0.267 | Peptidyltransferase inhibitor | 0.267 0.04 CID_65512 | CID_65512 | |
| 0.103 | 0.005 | 0.103 | Urate transporter 1 inhibitor | 0.078 0.008 CID_65512 | ||
| 0.178 | 0.081 | 0.178 | Hepatoprotectant | 0.143 0.117 CID_65512 | ||
| 0.106 | 0.009 | 0.152 | Carbonic anhydrase VII inhibitor | 0.152 0.006 CID_65512 | CID_65512 | |
| 0.1 | 0.004 | 0.1 | NMDA 2D receptor antagonist | 0.071 0.005 CID_65512 | ||
| 0.112 | 0.017 | 0.112 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.245 | 0.152 | 0.245 | Immunosuppressant | 0.205 0.192 CID_65512 | ||
| 0.239 | 0.146 | 0.239 | Vasodilator, coronary | |||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR group III) agonist | 0.06 0.018 CID_65512 | ||
| 0.11 | 0.018 | 0.11 | Leukotriene antagonist | 0.093 0.025 CID_65512 | ||
| 0.108 | 0.017 | 0.108 | Estrogen-related receptor beta agonist | 0.088 0.045 CID_65512 | ||
| 0.101 | 0.01 | 0.101 | Leukotriene B4 antagonist | 0.059 0.03 CID_65512 | ||
| 0.14 | 0.048 | 0.14 | Beta amyloid protein antagonist | |||
| 0.121 | 0.03 | 0.121 | ABCA1 expression enhancer | 0.09 0.066 CID_65512 | ||
| 0.114 | 0.023 | 0.114 | Purinergic P2X2 antagonist | |||
| 0.168 | 0.078 | 0.168 | Tumour necrosis factor antagonist | |||
| 0.094 | 0.005 | 0.094 | Retinoid X alpha receptor agonist | 0.033 0.027 CID_65512 | ||
| 0.099 | 0.011 | 0.165 | Dihydroorotate dehydrogenase inhibitor | 0.165 0.005 CID_65512 | CID_65512 | |
| 0.202 | 0.116 | 0.256 | Neuropeptide Y2 antagonist | 0.256 0.051 CID_65512 | CID_65512 | |
| 0.109 | 0.023 | 0.109 | Aminopeptidase I inhibitor | 0.091 0.033 CID_65512 | ||
| 0.091 | 0.006 | 0.091 | AICAR transformylase inhibitor | 0.072 0.009 CID_65512 | ||
| 0.097 | 0.013 | 0.097 | AMPA receptor antagonist | |||
| 0.13 | 0.046 | 0.13 | 5-Lipoxygenase inhibitor | 0.083 0.078 CID_65512 | ||
| 0.09 | 0.007 | 0.098 | Nicotinic acid receptor 2 agonist | 0.098 0.005 CID_65512 | CID_65512 | |
| 0.083 | 0.005 | 0.083 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_65512 | ||
| 0.162 | 0.084 | 0.241 | 3C-like protease (Human coronavirus) inhibitor | 0.241 0.031 CID_65512 | CID_65512 | |
| 0.285 | 0.21 | 0.373 | Caspase 9 stimulant | 0.373 0.128 CID_65512 | CID_65512 | |
| 0.102 | 0.027 | 0.102 | Interferon agonist | |||
| 0.126 | 0.051 | 0.135 | Transcription factor STAT6 inhibitor | 0.135 0.038 CID_65512 | CID_65512 | |
| 0.091 | 0.016 | 0.091 | Glutamate (mGluR7) antagonist | 0.062 0.06 CID_65512 | ||
| 0.083 | 0.008 | 0.083 | Phosphoglycerate kinase inhibitor | 0.044 0.016 CID_65512 | ||
| 0.095 | 0.021 | 0.095 | Carbonic anhydrase XII inhibitor | 0.081 0.025 CID_65512 | ||
| 0.119 | 0.045 | 0.119 | Toll-Like receptor 4 antagonist | 0.107 0.059 CID_65512 | ||
| 0.092 | 0.018 | 0.092 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 CID_65512 | ||
| 0.134 | 0.062 | 0.134 | Glutamate receptor antagonist | |||
| 0.079 | 0.006 | 0.079 | AMPA 4 receptor antagonist | |||
| 0.113 | 0.042 | 0.113 | Estrogen receptor beta antagonist | 0.1 0.065 CID_65512 | ||
| 0.078 | 0.008 | 0.078 | Factor III inhibitor | 0.065 0.014 CID_65512 | ||
| 0.171 | 0.101 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.135 0.134 CID_65512 | ||
| 0.078 | 0.008 | 0.078 | Retinoid X receptor agonist | |||
| 0.128 | 0.058 | 0.128 | Cholesterol synthesis inhibitor | 0.102 0.085 CID_65512 | ||
| 0.079 | 0.01 | 0.079 | Beta 2 adrenoreceptor agonist | 0.077 0.011 CID_65512 | ||
| 0.084 | 0.015 | 0.084 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.065 0.025 CID_65512 | ||
| 0.144 | 0.075 | 0.144 | MAP kinase kinase 4 inhibitor | |||
| 0.071 | 0.003 | 0.071 | Glutamate (mGluR3) agonist | 0.054 0.004 CID_65512 | ||
| 0.096 | 0.028 | 0.096 | Carbonic anhydrase inhibitor | 0.095 0.029 CID_65512 | ||
| 0.075 | 0.008 | 0.075 | Fumarate hydratase inhibitor | 0.04 0.019 CID_65512 | ||
| 0.161 | 0.095 | 0.161 | Platelet adhesion inhibitor | 0.141 0.117 CID_65512 | ||
| 0.121 | 0.054 | 0.121 | Estrogen antagonist | 0.106 0.083 CID_65512 | ||
| 0.075 | 0.009 | 0.1 | Heparanase inhibitor | 0.1 0.004 CID_65512 | CID_65512 | |
| 0.138 | 0.072 | 0.176 | Histone deacetylase SIRT1 inhibitor | 0.176 0.042 CID_65512 | CID_65512 | |
| 0.123 | 0.057 | 0.123 | Microtubule formation inhibitor | 0.105 0.082 CID_65512 | ||
| 0.07 | 0.005 | 0.07 | Beta adrenoreceptor agonist | 0.07 0.005 CID_65512 | ||
| 0.083 | 0.018 | 0.083 | Heat shock protein 90 beta antagonist | |||
| 0.071 | 0.006 | 0.071 | Retinoic acid alpha receptor agonist | 0.059 0.009 CID_65512 | ||
| 0.102 | 0.039 | 0.102 | Topoisomerase II alpha inhibitor | 0.093 0.044 CID_65512 | ||
| 0.072 | 0.01 | 0.072 | Glutamate (mGluR4) antagonist | 0.042 0.034 CID_65512 | ||
| 0.128 | 0.066 | 0.128 | MAP kinase kinase inhibitor | |||
| 0.071 | 0.009 | 0.071 | Glutamate (mGluR group III) antagonist | |||
| 0.155 | 0.094 | 0.195 | ATPase inhibitor | 0.195 0.041 CID_65512 | CID_65512 | |
| 0.069 | 0.008 | 0.12 | Neuraminidase (Influenza A) inhibitor | 0.12 0.004 CID_65512 | CID_65512 | |
| 0.085 | 0.025 | 0.085 | Carbonic anhydrase IX inhibitor | 0.072 0.031 CID_65512 | ||
| 0.113 | 0.053 | 0.113 | Beta glucuronidase inhibitor | 0.112 0.054 CID_65512 | ||
| 0.139 | 0.079 | 0.139 | Cyclooxygenase inhibitor | |||
| 0.071 | 0.012 | 0.071 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.072 | 0.013 | 0.075 | Lysophosphatidic acid 3 receptor antagonist | 0.075 0.011 CID_65512 | CID_65512 | |
| 0.07 | 0.012 | 0.07 | Thymidylate synthase inhibitor | |||
| 0.098 | 0.04 | 0.098 | I kappa B kinase inhibitor | |||
| 0.066 | 0.008 | 0.066 | AMPA 1 receptor antagonist | 0.034 0.018 CID_65512 | ||
| 0.073 | 0.015 | 0.084 | DNA helicase inhibitor | 0.084 0.01 CID_65512 | CID_65512 | |
| 0.151 | 0.094 | 0.151 | Nitric oxide antagonist | 0.133 0.114 CID_65512 | ||
| 0.138 | 0.082 | 0.141 | Thiol protease inhibitor | 0.141 0.078 CID_65512 | CID_65512 | |
| 0.069 | 0.014 | 0.069 | Adenosine deaminase inhibitor | 0.05 0.03 CID_65512 | ||
| 0.06 | 0.005 | 0.06 | Protein kinase (CK2) beta inhibitor | 0.044 0.01 CID_65512 | ||
| 0.245 | 0.19 | 0.376 | Transcription factor inhibitor | 0.376 0.119 CID_65512 | CID_65512 | |
| 0.079 | 0.025 | 0.083 | Carbonic anhydrase I inhibitor | 0.083 0.024 CID_65512 | CID_65512 | |
| 0.084 | 0.031 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.075 | 0.023 | 0.075 | Transcription factor RelA inhibitor | |||
| 0.075 | 0.023 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.061 | 0.01 | 0.061 | DNA gyrase subunit A inhibitor | 0.047 0.021 CID_65512 | ||
| 0.065 | 0.014 | 0.125 | Dihydroorotase inhibitor | 0.125 0.004 CID_65512 | CID_65512 | |
| 0.13 | 0.079 | 0.14 | Cytokine production inhibitor | 0.14 0.071 CID_65512 | CID_65512 | |
| 0.121 | 0.071 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.027 CID_65512 | CID_65512 | |
| 0.104 | 0.054 | 0.104 | Nitric-oxide synthase inhibitor | |||
| 0.057 | 0.007 | 0.057 | AMPA 3 receptor antagonist | 0.027 0.023 CID_65512 | ||
| 0.076 | 0.027 | 0.076 | Interferon inducer | |||
| 0.101 | 0.052 | 0.106 | Interleukin 12 antagonist | 0.106 0.045 CID_65512 | CID_65512 | |
| 0.075 | 0.027 | 0.076 | Carbonic anhydrase II inhibitor | 0.076 0.027 CID_65512 | CID_65512 | |
| 0.083 | 0.035 | 0.083 | Leukotriene synthesis inhibitor | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR4) agonist | 0.033 0.024 CID_65512 | ||
| 0.123 | 0.075 | 0.167 | Toll-Like receptor 2 antagonist | 0.167 0.041 CID_65512 | CID_65512 | |
| 0.118 | 0.071 | 0.157 | Histone deacetylase class III inhibitor | 0.157 0.038 CID_65512 | CID_65512 | |
| 0.077 | 0.03 | 0.089 | Beta adrenoreceptor antagonist | 0.089 0.022 CID_65512 | CID_65512 | |
| 0.058 | 0.011 | 0.058 | Nerve growth factor antagonist | 0.044 0.027 CID_65512 | ||
| 0.056 | 0.009 | 0.056 | Kainate receptor agonist | 0.042 0.028 CID_65512 | ||
| 0.077 | 0.031 | 0.077 | CDC25B inhibitor | 0.057 0.055 CID_65512 | ||
| 0.058 | 0.012 | 0.058 | Kainate receptor 2 antagonist | 0.031 0.03 CID_65512 | ||
| 0.074 | 0.029 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.093 0.017 CID_65512 | CID_65512 | |
| 0.051 | 0.005 | 0.07 | NMDA receptor glycine site antagonist | 0.07 0.004 CID_65512 | CID_65512 | |
| 0.062 | 0.017 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 CID_65512 | ||
| 0.057 | 0.013 | 0.057 | Dopamine D5 agonist | |||
| 0.179 | 0.135 | 0.179 | DNA damaging | |||
| 0.051 | 0.008 | 0.051 | Glutamate (mGluR8) antagonist | 0.035 0.026 CID_65512 | ||
| 0.18 | 0.137 | 0.18 | Spasmolytic | |||
| 0.049 | 0.007 | 0.054 | Purinergic P2Y14 antagonist | 0.054 0.006 CID_65512 | CID_65512 | |
| 0.045 | 0.004 | 0.047 | Beta 1 adrenoreceptor agonist | 0.047 0.004 CID_65512 | CID_65512 | |
| 0.081 | 0.041 | 0.081 | HIV-1 reverse transcriptase inhibitor | |||
| 0.045 | 0.006 | 0.045 | Kainate receptor 1 antagonist | 0.03 0.01 CID_65512 | ||
| 0.12 | 0.081 | 0.161 | Antibacterial (Helicobacter pylori) | 0.161 0.038 CID_65512 | CID_65512 | |
| 0.054 | 0.015 | 0.054 | Dihydrofolate reductase inhibitor | |||
| 0.098 | 0.059 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | 0.118 0.037 CID_65512 | CID_65512 | |
| 0.058 | 0.02 | 0.058 | Purinergic P2Y antagonist | 0.044 0.033 CID_65512 | ||
| 0.07 | 0.032 | 0.07 | I kappa B kinase 2 inhibitor | |||
| 0.077 | 0.039 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.054 CID_65512 | ||
| 0.062 | 0.024 | 0.07 | Leukotriene C antagonist | 0.07 0.014 CID_65512 | CID_65512 | |
| 0.05 | 0.012 | 0.05 | Integrin alpha2 antagonist | |||
| 0.096 | 0.059 | 0.096 | Breast cancer-resistant protein inhibitor | |||
| 0.045 | 0.008 | 0.045 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.086 | 0.048 | 0.086 | Thioredoxin reductase inhibitor | 0.077 0.072 CID_65512 | ||
| 0.088 | 0.051 | 0.088 | Histamine H2 receptor antagonist | |||
| 0.068 | 0.032 | 0.068 | Phosphodiesterase 1C inhibitor | 0.06 0.049 CID_65512 | ||
| 0.062 | 0.025 | 0.07 | Factor IXa inhibitor | 0.07 0.021 CID_65512 | CID_65512 | |
| 0.093 | 0.057 | 0.093 | Thioredoxin inhibitor | |||
| 0.05 | 0.015 | 0.05 | Arginase inhibitor | |||
| 0.049 | 0.013 | 0.049 | Retinoid X receptor antagonist | 0.043 0.019 CID_65512 | ||
| 0.088 | 0.053 | 0.091 | Hematopoietic | 0.091 0.048 CID_65512 | CID_65512 | |
| 0.055 | 0.02 | 0.055 | Mannosidase inhibitor | 0.042 0.036 CID_65512 | ||
| 0.059 | 0.025 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.021 CID_65512 | CID_65512 | |
| 0.156 | 0.121 | 0.156 | Focal adhesion kinase 2 inhibitor | |||
| 0.048 | 0.014 | 0.048 | RNA-directed RNA polymerase inhibitor | 0.037 0.021 CID_65512 | ||
| 0.086 | 0.052 | 0.086 | Inducible nitric-oxide synthase inhibitor | |||
| 0.05 | 0.016 | 0.05 | GABA uptake inhibitor | |||
| 0.043 | 0.01 | 0.043 | Leukotriene B4 receptor 1 antagonist | |||
| 0.13 | 0.097 | 0.13 | Insulin secretagoues | |||
| 0.045 | 0.012 | 0.045 | Purinergic P2Y2 antagonist | 0.034 0.023 CID_65512 | ||
| 0.036 | 0.004 | 0.043 | Nicotinic acid receptor 1 antagonist | 0.043 0.003 CID_65512 | CID_65512 | |
| 0.039 | 0.007 | 0.039 | Retinoic acid receptor agonist | 0.035 0.008 CID_65512 | ||
| 0.078 | 0.046 | 0.078 | CDC25A inhibitor | |||
| 0.036 | 0.005 | 0.036 | Retinoic acid alpha receptor antagonist | 0.029 0.007 CID_65512 | ||
| 0.127 | 0.095 | 0.127 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.051 | 0.02 | 0.051 | Guanylate cyclase inhibitor | |||
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | 0.027 0.023 CID_65512 | ||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.059 | 0.028 | 0.059 | Urokinase inhibitor | |||
| 0.086 | 0.056 | 0.097 | Bcr-Abl kinase inhibitor | 0.097 0.044 CID_65512 | CID_65512 | |
| 0.033 | 0.003 | 0.033 | Glutamate (mGluR6) agonist | 0.015 0.006 CID_65512 | ||
| 0.035 | 0.005 | 0.035 | Retinoic acid gamma receptor agonist | 0.03 0.007 CID_65512 | ||
| 0.088 | 0.058 | 0.088 | Interleukin 5 antagonist | 0.081 0.07 CID_65512 | ||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.049 | 0.02 | 0.05 | Leukotriene A4 hydrolase inhibitor | 0.05 0.02 CID_65512 | CID_65512 | |
| 0.033 | 0.005 | 0.033 | Retinoic acid receptor antagonist | 0.025 0.008 CID_65512 | ||
| 0.065 | 0.037 | 0.065 | Beta tubulin antagonist | |||
| 0.041 | 0.014 | 0.041 | Retinoid X alpha receptor antagonist | 0.037 0.019 CID_65512 | ||
| 0.059 | 0.031 | 0.059 | Alpha tubulin antagonist | |||
| 0.031 | 0.004 | 0.048 | Neuraminidase (Influenza B) inhibitor | 0.048 0.003 CID_65512 | CID_65512 | |
| 0.083 | 0.056 | 0.113 | Glutathione S-transferase inhibitor | 0.113 0.027 CID_65512 | CID_65512 | |
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.038 | 0.011 | 0.038 | Lysine carboxypeptidase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | |||
| 0.057 | 0.032 | 0.057 | Alpha-mannosidase inhibitor | |||
| 0.031 | 0.007 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.049 | 0.025 | 0.049 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.084 | 0.06 | 0.121 | Androgen antagonist | 0.121 0.033 CID_65512 | CID_65512 | |
| 0.084 | 0.06 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.039 | 0.015 | 0.039 | HCV NS5B polymerase inhibitor | 0.028 0.026 CID_65512 | ||
| 0.056 | 0.033 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.052 | 0.029 | 0.052 | Sodium/calcium exchanger inhibitor | |||
| 0.058 | 0.036 | 0.058 | Protein kinase C eta inhibitor | |||
| 0.051 | 0.029 | 0.051 | Dopamine beta hydroxylase inhibitor | |||
| 0.042 | 0.02 | 0.042 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.033 | 0.012 | 0.033 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.077 | 0.056 | 0.077 | Glutamate receptor agonist | |||
| 0.061 | 0.041 | 0.061 | Cyclin D1 inhibitor | 0.058 0.046 CID_65512 | ||
| 0.046 | 0.027 | 0.046 | Geranyltranstransferase inhibitor | |||
| 0.095 | 0.075 | 0.095 | Folate antagonist | |||
| 0.029 | 0.01 | 0.029 | Glutamate (mGluR1) agonist | 0.023 0.02 CID_65512 | ||
| 0.088 | 0.069 | 0.088 | Pim-1 kinase inhibitor | |||
| 0.03 | 0.012 | 0.056 | Thyroid hormone agonist | 0.056 0.004 CID_65512 | CID_65512 | |
| 0.041 | 0.023 | 0.047 | Leukotriene C4 antagonist | 0.047 0.013 CID_65512 | CID_65512 | |
| 0.06 | 0.042 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.071 0.027 CID_65512 | CID_65512 | |
| 0.024 | 0.006 | 0.024 | Estrogen-related receptor gamma agonist | 0.02 0.01 CID_65512 | ||
| 0.041 | 0.024 | 0.041 | Factor VIIa inhibitor | |||
| 0.066 | 0.049 | 0.066 | Potassium channel (ATP-sensitive) blocker | |||
| 0.021 | 0.004 | 0.021 | Retinoic acid receptor gamma antagonist | 0.014 0.005 CID_65512 | ||
| 0.029 | 0.012 | 0.029 | Vanilloid 2 agonist | |||
| 0.025 | 0.008 | 0.025 | Retinoic acid beta receptor agonist | 0.021 0.012 CID_65512 | ||
| 0.03 | 0.013 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 CID_65512 | CID_65512 | |
| 0.02 | 0.004 | 0.02 | Retinoic acid beta receptor antagonist | 0.015 0.005 CID_65512 | ||
| 0.048 | 0.033 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 CID_65512 | CID_65512 | |
| 0.034 | 0.02 | 0.034 | Protein kinase C beta I inhibitor | 0.031 0.03 CID_65512 | ||
| 0.04 | 0.026 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.057 | 0.043 | 0.065 | Sphingosine 1-phosphate receptor 3 antagonist | 0.065 0.031 CID_65512 | CID_65512 | |
| 0.055 | 0.041 | 0.066 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 CID_65512 | CID_65512 | |
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | |||
| 0.029 | 0.015 | 0.031 | Calcium-sensing receptor agonist | 0.031 0.013 CID_65512 | CID_65512 | |
| 0.032 | 0.019 | 0.032 | AMPA 2 receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.026 | 0.013 | 0.026 | Retinoid X gamma receptor agonist | |||
| 0.058 | 0.044 | 0.059 | Androgen agonist | 0.059 0.043 CID_65512 | CID_65512 | |
| 0.056 | 0.043 | 0.063 | Plasminogen activator inhibitor | 0.063 0.037 CID_65512 | CID_65512 | |
| 0.02 | 0.008 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_65512 | ||
| 0.017 | 0.005 | 0.02 | Thrombopoietin agonist | 0.02 0.004 CID_65512 | CID_65512 | |
| 0.025 | 0.012 | 0.025 | Leukotriene B4 receptor 2 antagonist | |||
| 0.04 | 0.028 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.017 | 0.005 | 0.021 | Beta 3 adrenoreceptor agonist | 0.021 0.005 CID_65512 | CID_65512 | |
| 0.028 | 0.016 | 0.028 | Retinoid X gamma receptor antagonist | |||
| 0.056 | 0.044 | 0.056 | Aromatase inhibitor | |||
| 0.053 | 0.042 | 0.053 | Thromboxane synthase inhibitor | |||
| 0.021 | 0.01 | 0.021 | Antibiotic Anthracycline-like | |||
| 0.143 | 0.133 | 0.143 | Death-associated protein kinase 3 inhibitor | |||
| 0.157 | 0.147 | 0.157 | Vasodilator | |||
| 0.032 | 0.022 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.119 | 0.109 | 0.119 | Acetylcholine M1 receptor antagonist | |||
| 0.022 | 0.013 | 0.022 | Retinoid X beta receptor agonist | |||
| 0.034 | 0.025 | 0.034 | Glutamate (mGluR group II) agonist | |||
| 0.099 | 0.09 | 0.099 | Acetylcholine release stimulant | |||
| 0.113 | 0.105 | 0.119 | Vanilloid 1 agonist | 0.119 0.091 CID_65512 | CID_65512 | |
| 0.069 | 0.061 | 0.069 | Na+ K+ transporting ATPase inhibitor | |||
| 0.082 | 0.074 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.081 | 0.074 | 0.111 | Potassium channel activator | 0.111 0.038 CID_65512 | CID_65512 | |
| 0.026 | 0.02 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.114 | 0.108 | 0.171 | Cytidine deaminase inhibitor | 0.171 0.061 CID_65512 | CID_65512 | |
| 0.049 | 0.043 | 0.049 | Autotaxin inhibitor | |||
| 0.049 | 0.043 | 0.049 | Ribonucleotide reductase inhibitor | |||
| 0.048 | 0.042 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.009 | 0.003 | 0.009 | Insulin like growth factor 3 antagonist | |||
| 0.087 | 0.082 | 0.087 | Topoisomerase I inhibitor | |||
| 0.039 | 0.034 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_65512 | CID_65512 | |
| 0.028 | 0.023 | 0.028 | Factor VII inhibitor | |||
| 0.087 | 0.083 | 0.087 | Phosphodiesterase 6D inhibitor | |||
| 0.053 | 0.049 | 0.053 | Botulinum neurotoxin type A inhibitor | |||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.054 | 0.052 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.044 CID_65512 | CID_65512 | |
| 0.186 | 0.184 | 0.27 | Thioredoxin glutathione reductase inhibitor | 0.27 0.122 CID_65512 | CID_65512 | |
| 0.028 | 0.026 | 0.028 | Glutamate (mGluR2) agonist | |||
| 0.028 | 0.026 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.027 0.026 CID_65512 | ||
| 0.032 | 0.031 | 0.039 | 5-Alpha-reductase inhibitor | 0.039 0.025 CID_65512 | CID_65512 | |
| 0.019 | 0.018 | 0.019 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.071 | 0.073 | 0.105 | Glycine receptor antagonist | 0.105 0.028 CID_65512 | CID_65512 | |
| 0.007 | 0.009 | 0.016 | Thyroid hormone beta agonist | 0.016 0.004 CID_65512 | CID_65512 | |
| 0.03 | 0.033 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 CID_65512 | CID_65512 | |
| 0.029 | 0.033 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.014 CID_65512 | CID_65512 | |
| 0.119 | 0.123 | 0.139 | Growth hormone agonist | 0.139 0.097 CID_65512 | CID_65512 | |
| 0.015 | 0.021 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_65512 | CID_65512 | |
| 0.028 | 0.035 | 0.042 | Carnitine palmitoyltransferase inhibitor | 0.042 0.014 CID_65512 | CID_65512 | |
| 0.012 | 0.019 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 CID_65512 | CID_65512 | |
| 0.012 | 0.019 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 CID_65512 | CID_65512 | |
| 0.01 | 0.021 | 0.017 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 CID_65512 | CID_65512 | |
| 0.032 | 0.044 | 0.045 | CDK5/p25 inhibitor | 0.045 0.024 CID_65512 | CID_65512 | |
| 0.015 | 0.028 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 CID_65512 | CID_65512 | |
| 0.025 | 0.038 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 CID_65512 | CID_65512 | |
| 0.054 | 0.074 | 0.095 | Prostaglandin-E synthase inhibitor | 0.095 0.029 CID_65512 | CID_65512 | |
| 0.007 | 0.029 | 0.014 | Carbonic anhydrase XI inhibitor | 0.014 0.007 CID_65512 | CID_65512 | |
| 0.008 | 0.031 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | 0.012 0.011 CID_65512 | CID_65512 | |
| 0.064 | 0.096 | 0.083 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.041 CID_65512 | CID_65512 | |
| 0.022 | 0.055 | 0.03 | Caspase 6 inhibitor | 0.03 0.021 CID_65512 | CID_65512 | |
| 0.044 | 0.078 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | 0.056 0.038 CID_65512 | CID_65512 | |
| 0.041 | 0.076 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.045 CID_65512 | CID_65512 | |
| 0.086 | 0.121 | 0.148 | CDK3/cyclin E inhibitor | 0.148 0.028 CID_65512 | CID_65512 | |
| 0.017 | 0.054 | 0.031 | Caspase 2 inhibitor | 0.031 0.023 CID_65512 | CID_65512 | |
| 0.161 | 0.2 | 0.316 | Thyroid hormone antagonist | 0.316 0.086 CID_65512 | CID_65512 | |
| 0.106 | 0.146 | 0.131 | NOS3 expression enhancer | 0.131 0.096 CID_65512 | CID_65512 | |
| 0.033 | 0.073 | 0.045 | Purinergic P2X4 antagonist | 0.045 0.034 CID_65512 | CID_65512 | |
| 0.038 | 0.08 | 0.066 | Selectin antagonist | 0.066 0.045 CID_65512 | CID_65512 | |
| 0.035 | 0.083 | 0.063 | Myc inhibitor | 0.063 0.026 CID_65512 | CID_65512 | |
| 0.153 | 0.201 | 0.17 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.134 CID_65512 | CID_65512 | |
| 0.045 | 0.098 | 0.061 | Sirtuin 1 inhibitor | 0.061 0.058 CID_65512 | CID_65512 | |
| 0.017 | 0.079 | 0.033 | Epoxide hydrolase 1 inhibitor | 0.033 0.019 CID_65512 | CID_65512 | |
| 0.048 | 0.111 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 CID_65512 | CID_65512 | |
| 0.141 | 0.204 | 0.19 | 5 Hydroxytryptamine 1E antagonist | 0.19 0.142 CID_65512 | CID_65512 | |
| 0.045 | 0.118 | 0.074 | Epoxide hydrolase inhibitor | 0.074 0.049 CID_65512 | CID_65512 | |
| 0.066 | 0.142 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | 0.086 0.053 CID_65512 | CID_65512 | |
| 0.139 | 0.218 | 0.293 | Thyroid hormone beta antagonist | 0.293 0.092 CID_65512 | CID_65512 | |
| 0.044 | 0.142 | 0.062 | Kallikrein 7 inhibitor | 0.062 0.049 CID_65512 | CID_65512 | |
| 0.145 | 0.246 | 0.204 | Angiogenesis inhibitor | 0.204 0.165 CID_65512 | CID_65512 | |
| 0.066 | 0.179 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.088 CID_65512 | CID_65512 | |
| 0.034 | 0.151 | 0.069 | Histone deacetylase SIRT2 inhibitor | 0.069 0.057 CID_65512 | CID_65512 | |
| 0.121 | 0.277 | 0.29 | Calpain 2 inhibitor | 0.29 0.121 CID_65512 | CID_65512 | |
| 0.093 | 0.272 | 0.175 | Calpain inhibitor | 0.175 0.141 CID_65512 | CID_65512 | |
| 0.081 | 0.317 | 0.225 | Beta lactamase inhibitor | 0.225 0.17 CID_65512 | CID_65512 | |
| 0.094 | 0.35 | 0.16 | Cyclin-dependent kinase 3 inhibitor | 0.16 0.076 CID_65512 | CID_65512 | |
| 0.082 | 0.369 | 0.195 | Death-associated protein kinase 2 inhibitor | 0.195 0.038 CID_65512 | CID_65512 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |